In other words, downregulation of IL-6 secreted by endothelial cells inhibits phosphorylation of STAT3 in tumor cells, which will then secrete less angiogenic factors (e.g. CXCL8) causing a decrease in tumor microvessel density and tumor growth. The gene discussed is STAT3; the disease is neoplasm.